IDO1 and neoplasm: This process is catalyzed by key enzymes, including indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase 2 (TDO2) and the levels of these metabolites are closely associated with the malignant features of the tumour (Refs 6, 7).